Pfizer is expected to report earnings of $0.57 on revenue of $13.43bn.

Pfizer is currently trading at around $36.19 a share. The pharma giant is due to report earnings tomorrow which may have an influence on its share price in the short-term. Looking at the chart on the daily timeframe, we can see that the price tried to break out of the descending triangle last Tuesday but it got rejected. The price is now approaching a key support level along the lower trendline of the triangle, sitting at $35.36. A break below this point could see the price slide lower towards the Covid levels of $33-$34 a share. The bias remains slightly bearish, but if we see some consolidation, we will then look at resistance sitting at $36.48 followed by $36.92, which is along the descending trendline. A break and close above the trendline may be an indication of a potential move higher with the target then of $37.78. The technical indicators are a little mixed, MACD is positive but volume is fading, seems like it can turn to a neutral stance. And RSI is negative as it reads 43.